SLC2A1 and malaria: A counterscreen of five PfHT inhibitory hits selected from a library of 400 compounds known to inhibit erythrocytic development of P. falciparum (Medicines for Malaria Venture (MMV) Malaria Box) were made against the human orthologues GLUT1, -2, -3, and -4.